ReviewFrontiers in immunology2022

Long-term benefit of immunotherapy in a patient with squamous lung cancer exhibiting mismatch repair deficient/high microsatellite instability/high tumor mutational burden: A case report and literature review.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.